Philippe-Antoine Bilodeau, M.D.,C.M.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Autoantibodies | 5 | 2024 | 2112 | 0.930 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2024 | 666 | 0.680 |
Why?
|
Myelitis, Transverse | 1 | 2019 | 39 | 0.660 |
Why?
|
Puerperal Disorders | 1 | 2019 | 304 | 0.540 |
Why?
|
Neuromyelitis Optica | 3 | 2024 | 266 | 0.490 |
Why?
|
Muscular Atrophy | 1 | 2016 | 335 | 0.430 |
Why?
|
Ubiquitin | 1 | 2016 | 839 | 0.370 |
Why?
|
Education, Medical, Undergraduate | 1 | 2019 | 1086 | 0.340 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2016 | 1313 | 0.340 |
Why?
|
Multiple Sclerosis | 5 | 2024 | 3212 | 0.280 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2019 | 2152 | 0.270 |
Why?
|
Students, Medical | 1 | 2019 | 1962 | 0.260 |
Why?
|
Oligodendroglia | 2 | 2019 | 543 | 0.230 |
Why?
|
Aquaporin 4 | 2 | 2024 | 161 | 0.210 |
Why?
|
Herpesvirus 4, Human | 2 | 2024 | 1078 | 0.190 |
Why?
|
Mycophenolic Acid | 1 | 2024 | 346 | 0.190 |
Why?
|
Autoimmune Diseases | 2 | 2024 | 2222 | 0.180 |
Why?
|
Muscle, Skeletal | 1 | 2016 | 4961 | 0.180 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2024 | 617 | 0.180 |
Why?
|
Prednisone | 1 | 2024 | 1562 | 0.160 |
Why?
|
Antigen Presentation | 1 | 2024 | 1250 | 0.160 |
Why?
|
Gangliosides | 1 | 2019 | 132 | 0.150 |
Why?
|
Myelin Sheath | 2 | 2019 | 652 | 0.140 |
Why?
|
Models, Organizational | 1 | 2019 | 548 | 0.130 |
Why?
|
Recurrence | 2 | 2024 | 8506 | 0.110 |
Why?
|
Drug Monitoring | 1 | 2019 | 960 | 0.110 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1510 | 0.100 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2024 | 4404 | 0.100 |
Why?
|
Immunoglobulin G | 2 | 2024 | 4526 | 0.100 |
Why?
|
Muscle Proteins | 1 | 2016 | 1160 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2019 | 1584 | 0.080 |
Why?
|
Immunotherapy | 1 | 2024 | 4752 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2024 | 9372 | 0.060 |
Why?
|
Humans | 14 | 2024 | 765823 | 0.050 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 2024 | 158 | 0.050 |
Why?
|
Cell Death | 2 | 2019 | 1678 | 0.050 |
Why?
|
Antigen-Antibody Complex | 1 | 2024 | 508 | 0.050 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2024 | 824 | 0.040 |
Why?
|
Complement System Proteins | 1 | 2024 | 714 | 0.040 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2019 | 17 | 0.040 |
Why?
|
Hospitals, General | 1 | 2024 | 802 | 0.040 |
Why?
|
Endoplasmic Reticulum | 1 | 2024 | 1132 | 0.040 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2019 | 183 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2024 | 921 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 24278 | 0.040 |
Why?
|
HIV Infections | 1 | 2024 | 17530 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2024 | 1856 | 0.030 |
Why?
|
Glycoproteins | 1 | 2024 | 2195 | 0.030 |
Why?
|
Child | 1 | 2024 | 80509 | 0.030 |
Why?
|
Caspase 3 | 1 | 2017 | 731 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2024 | 81505 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2024 | 3228 | 0.030 |
Why?
|
Lymphocyte Activation | 1 | 2024 | 5501 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 36542 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2024 | 3051 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2024 | 4779 | 0.020 |
Why?
|
Cell Lineage | 1 | 2019 | 2573 | 0.020 |
Why?
|
Cytokines | 1 | 2024 | 7425 | 0.020 |
Why?
|
Animals | 2 | 2017 | 168730 | 0.020 |
Why?
|
Disease Progression | 1 | 2024 | 13613 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 8105 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11033 | 0.020 |
Why?
|
Adult | 1 | 2019 | 223055 | 0.010 |
Why?
|
Female | 2 | 2024 | 396050 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2019 | 18970 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2019 | 11643 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 11888 | 0.010 |
Why?
|
Rats | 1 | 2017 | 23707 | 0.010 |
Why?
|
Cohort Studies | 1 | 2023 | 41643 | 0.010 |
Why?
|
Male | 1 | 2024 | 363740 | 0.000 |
Why?
|